Immuno-positron emission tomography (immunoPET) is a molecular imaging modality
combining the high sensitivity of PET with the specific targeting ability of monoclonal …

One of the most common cancers among men worldwide (Fig. 1) is prostate cancer (PCa). 1
Prostate-specific membrane antigen (PSMA) is a valuable target for the diagnosis of PCa …

A wide variety of radiolabeled peptide analogs for specific targeting of cholecystokinin-2
receptors (CCK2R) has been developed in the last decades. Peptide probes based on the …

Thyroid cancer, specifically differentiated thyroid carcinoma (DTC), is one of the most
prevalent endocrine malignancies worldwide. Radioactive iodine therapy (RAIT) using I-131 …

Thyroid cancer (TC) represents less than 1% of all newly diagnosed malignancies. In some
selected cases, with a high clinical suspicion for disease but negative I-131 scan, positron …

The ultimate judgment regarding the propriety of any specific procedure or course of action
must be made by the physician in light of all the circumstances presented. Thus, an …

Dedifferentiated thyroid cancer is the major cause of mortality in thyroid cancer and is
difficult to treat. Hence, the essential molecular mechanisms involved in dedifferentiation …

In the last two decades, the demand for a personalized therapeutic approach has been
constantly increasing, mainly due to the need to develop ever more effective therapeutic …

Thyroid cancers are the most frequent endocrine cancers and their incidence is increasing
worldwide. Thyroid nodules occur in over 19–68% of the population, but only 7–15% of them …

Personalized diagnosis can save unnecessary thyroid surgeries, in cases of indeterminate
thyroid nodules, when clinicians tend to aggressively treat all these patients. Personalized …